MTARC1 and Hepatic fibrosis: The missense variant of the Mitochondrial Amidoxime Reducing Component 1 (MTARC1 p.A165T) has been shown to be protective against hepatic fibrosis in obese individuals and buffers the effects of the PNPLA3 p.I148M allele.74